Eloxx Pharmaceuticals, Inc.
USD11.96
+0.32 (+2.70%)
CEO
Sumit Aggarwal
IPO Date
2026-06-09
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$11.56
Prev. Close
$11.65
Day Low
$11.56
Day High
$11.96
52W Low
$8.20
52W High
$17.50
Market Cap
$0.09B
Volume
0.03M
| Acquired |
| 361,578 |
| $0.00 |
| 17 Jun 2026 | Domicilium Real Estate Fund III LP | 10 percent owner | J-Other | Acquired | 238,422 | $0.00 |
| 17 Jun 2026 | Domicilium Real Estate Fund III LP | 10 percent owner | J-Other | Acquired | 361,578 | $0.00 |
| 17 Jun 2026 | Domicilium Real Estate Fund III LP | 10 percent owner | Disposed | 0 | $0.00 |
| 17 Jun 2026 | Domicilium Real Estate Fund III LP | 10 percent owner | Disposed | 611,317 | $0.11 |
| 10 Jun 2026 | Webster Stephen W | director | A-Award | Acquired | 13,587 | $11.00 |
| 10 Jun 2026 | Walts Alan Edmund | director | A-Award | Acquired | 8,590 | $11.00 |
| 10 Jun 2026 | Kjellson Nina S | director | A-Award | Acquired | 13,587 | $11.00 |
| 10 Jun 2026 | Aggarwal Sumit | director, officer: President and CEO | A-Award | Acquired | 328,833 | $1.65 |